SCHEMBL2120248

SCHEMBL2120248

NC(CS(=O)(=O)O)(c1ccccc1)S(=O)(=O)C(N)(CS(=O)(=O)O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA5A P35218 1/20 0.38
CA9 Q16790 1/20 0.38
KCNN4 O15554 2/20 0.38
MAPT P10636 3/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP13 P45452 1/20 0.35
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958575 0.89 CYP2D6 (0.39) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL28114206 0.80 CYP1A2 (0.41) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL27725243 0.77 CYP1A2 (0.43) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL2120252 0.77 CYP2D6 (0.39) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL27746077 0.77 CYP1A2 (0.43) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL27599834 0.76 CYP1A2 (0.46) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL28533116 0.74 TAAR1 (0.50) MAPTTSHRCYP3A4SMN1; SMN2KMT2A
SCHEMBL27560472 0.73 CYP2D6 (0.39) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL8934011 0.72 TSHR (0.38) CYP1A2CYP2D6CA1CA2CA5A
SCHEMBL28084413 0.72 PTPN1 (0.40) CYP1A2CYP2D6CA1CA2CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452608-B2 Ink, ink cartridge and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2016-09-27 US disclosed
EP-2662423-B1 Ink, ink cartridge and ink jet recording method CANON KK (JP) 2015-10-14 EP disclosed
US-20130300804-A1 INK, INK CARTRIDGE AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2013-11-14 US disclosed
EP-2662423-A1 Ink, ink cartridge and ink jet recording method Canon Kabushiki Kaisha (JP) 2013-11-13 EP disclosed
US-20120092598-A1 SURFACE MODIFIED ORGANIC BLACK PIGMENTS, SURFACE MODIFIED CARBON BLACKS, PIGMENT MIXTURES USING THEM, AND LOW DIELECTRIC BLACK DISPERSIONS, COATINGS, FILMS, BLACK MATRICES, AND DEBVICES CONTAINING SAME CABOT CORPORATION (US) 2012-04-19 US disclosed
EP-1953200-B1 AQUEOUS INK, INK-JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK-JET RECORDING DEVICE CANON KK (JP) 2011-08-03 EP disclosed
EP-1953200-A1 AQUEOUS INK, INK-JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK-JET RECORDING DEVICE Canon Kabushiki Kaisha (JP) 2008-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120092598-A1 SURFACE MODIFIED ORGANIC BLACK PIGMENTS, SURFACE MODIFIED CARBON BLACKS, PIGMENT MIXTURES USING THEM, AND LOW DIELECTRIC BLACK DISPERSIONS, COATINGS, FILMS, BLACK MATRICES, AND DEBVICES CONTAINING SAME TYR, CDYL, CD99 CYP1A2 313/4885CYP2D6 1106/4885CA1 4141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.